Does EMTRICITABINE Cause Therapy cessation? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Therapy cessation have been filed in association with EMTRICITABINE (Truvada). This represents 0.1% of all adverse event reports for EMTRICITABINE.
5
Reports of Therapy cessation with EMTRICITABINE
0.1%
of all EMTRICITABINE reports
0
Deaths
3
Hospitalizations
How Dangerous Is Therapy cessation From EMTRICITABINE?
Of the 5 reports, 3 (60.0%) required hospitalization.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMTRICITABINE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does EMTRICITABINE Cause?
Foetal exposure during pregnancy (609)
Drug resistance (370)
Virologic failure (331)
Immune reconstitution inflammatory syndrome (262)
Exposure during pregnancy (212)
Drug ineffective (196)
Pathogen resistance (166)
Viral mutation identified (161)
Maternal exposure during pregnancy (160)
Death (154)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which EMTRICITABINE Alternatives Have Lower Therapy cessation Risk?
EMTRICITABINE vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR ALAFENAMIDE
EMTRICITABINE vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL
EMTRICITABINE vs EMTRICITABINE\TENOFOVIR
EMTRICITABINE vs EMTRICITABINE\TENOFOVIR ALAFENAMIDE
EMTRICITABINE vs EMTRICITABINE/TENOFOVIR DISOPROXIL